CompletedNot Applicable

The Norwegian Stroke in the Young Study II

Norway130 participantsStarted 2016-03-01

Plain-language summary

NOR-SYS II is designed for finding the cause of acute ischemic stroke lesions in Young adults, age 15 to 49 years. Risk factors, arterial wall changes by intima-media thickness and plaques and consequences of stroke are examined by standardized diagnostics.

Who can participate

Age range15 Years – 49 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Documented acute, arterial ischemic stroke * Speaks Norwegian fluently Exclusion Criteria: * Post-traumatic and procedure related stroke * Sinus venous thrombosis, sepsis and endocarditis * Serious co-morbidity, such as advanced cancer with "end-of-life stroke". * Patients mentally retarded or with severe psychiatric disease who do not accept the diagnosis and who would need sedation to perform clinical diagnostics.

What they're measuring

Established atherosclerosis

Timeframe: Established atherosclerosis will serve as outcome measure for data collected during hospital stay and will be related to risk factors. The data will be presented one year after finishing the 5-years of inclusion of the whole study group.

Trial details

NCT IDNCT02762396

SponsorHaukeland University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-02-28

View on ClinicalTrials.gov More Ischemic Stroke at a Young Age trials